India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Mix-n-Stain CF Dye IgM Antibody Labeling Kits address longstanding challenges for labeling IgM antibodies by offering efficient and convenient conjugation with bright CF Dyes
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
The new Biolys provides higher concentration of L-lysine
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Subscribe To Our Newsletter & Stay Updated